Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
25%
OVERLAP
BY WEIGHT
55
# OF OVERLAPPING
HOLDINGS
BMED
115
HOLDINGS
52%
ALSO IN IBBQ
IBBQ
208
HOLDINGS
26%
ALSO IN BMED
SECTOR DRIFT (BMED minus IBBQ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in IBBQ |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.7% | 8.0% | 3.7% |
 |
ARGENX SE ADR | 3.3% | 2.2% | 2.2% |
|
NEUROCRINE BIOSCIENCES INC | 1.5% | 1.3% | 1.3% |
|
AMGEN INC | 1.3% | 7.4% | 1.3% |
|
BEIGENE LTD. SPONSORED ADR | 1.4% | 1.3% | 1.3% |
BMED Overweight Relative to IBBQ
|
BOSTON SCIENTIFIC CORP | 4.9% |
|
INTUITIVE SURGICAL INC | 4.9% |
 |
ROCHE HOLDING AG-BR | 3.4% |
|
ABBVIE INC | 3.1% |
|
LONZA GROUP AG-REG | 2.7% |
|
ABBOTT LABORATORIES | 2.7% |
 |
MEDTRONIC PLC | 2.3% |
|
UCB SA | 2.2% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% |
|
REPLIGEN CORP | 2.1% |
BMED Underweight Relative to IBBQ
|
REGENERON PHARMACEUTICALS | -6.3% |
|
AMGEN INC | -6.1% |
|
VERTEX PHARMACEUTICALS INC | -5.9% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.7% |
|
GILEAD SCIENCES INC | -4.4% |
|
ALNYLAM PHARMACEUTICALS INC | -4.3% |
|
SUMMIT THERAPEUTICS INC | -2.3% |
|
ROYALTY PHARMA PLC CLASS A | -1.7% |
|
INCYTE CORP | -1.6% |
|
ILLUMINA INC | -1.6% |